Home /
Eliminate the syringe with epithelial delivery: Intradermal and inhaled/nasal systems
February 8, 2024
As vaccine development becomes more and more competitive, companies are increasingly exploring delivery routes beyond the traditional needle and syringe. Inhaled vaccine and microneedle array patch platforms are two promising options. In this presentation, Head Kindeva SAB, John Patton, and Associate Director, Product and Process Development, Tim Peterson, share their insights on epithelial vaccine delivery.
Download your copy to discover:
- The current landscape of vaccine development
- Advantages of epithelial delivery
- An overview of particle engineering and spray drying technology to enhance stability of inhaled vaccines
- An introduction to intradermal vaccine delivery platforms and their benefits for mRNA delivery
Get Your Copy Now
Fields marked with a * are required.
Related resources
Explore our other resources to discover valuable insights on the latest trends in drug delivery.
Let’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.